TY - JOUR AU - Howes, R. E. AU - Reiner, R. C. AU - Battle, K. E. PY - 2015 DA - 2015// TI - Plasmodium vivax transmission in Africa JO - PLoS Negl Trop Dis VL - 9 UR - https://doi.org/10.1371/journal.pntd.0004222 DO - 10.1371/journal.pntd.0004222 ID - Howes2015 ER - TY - JOUR AU - Mühlberger, N. AU - Jelinek, T. AU - Gascon, J. PY - 2004 DA - 2004// TI - Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop JO - Malaria J VL - 3 UR - https://doi.org/10.1186/1475-2875-3-5 DO - 10.1186/1475-2875-3-5 ID - Mühlberger2004 ER - TY - JOUR AU - Elliot, J. H. AU - O’Brien, D. AU - Leder, K. PY - 2004 DA - 2004// TI - Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers JO - J Travel Med VL - 11 UR - https://doi.org/10.2310/7060.2004.19004 DO - 10.2310/7060.2004.19004 ID - Elliot2004 ER - TY - JOUR AU - Menard, D. AU - Barnadas, C. AU - Bouchier, C. PY - 2010 DA - 2010// TI - Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.0912496107 DO - 10.1073/pnas.0912496107 ID - Menard2010 ER - TY - JOUR AU - Culleton, R. AU - Ndounga, M. AU - Zeyrek, F. Y. PY - 2009 DA - 2009// TI - Evidence for transmission of Plasmodium vivax in the Republic of the Congo, west central Africa JO - J Infect Dis VL - 200 UR - https://doi.org/10.1086/644510 DO - 10.1086/644510 ID - Culleton2009 ER - TY - JOUR AU - Guerra, C. A. AU - Howes, R. E. AU - Patil, A. P. PY - 2010 DA - 2010// TI - The international limits and population at risk of Plasmodium vivax transmission in 2009 JO - PLoS Negl Trop Dis VL - 4 UR - https://doi.org/10.1371/journal.pntd.0000774 DO - 10.1371/journal.pntd.0000774 ID - Guerra2010 ER - TY - STD TI - Howes RE, Battle KE, Mendis KN, et al. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg 2016; 95(supplement 6): in press. ID - ref7 ER - TY - JOUR AU - Baird, J. K. PY - 2013 DA - 2013// TI - Evidence and implications of mortality associated with acute Plasmodium vivax malaria JO - Clin Microbiol Rev VL - 26 UR - https://doi.org/10.1128/CMR.00074-12 DO - 10.1128/CMR.00074-12 ID - Baird2013 ER - TY - JOUR AU - Anstey, N. M. AU - Douglas, N. M. AU - Poespoprodjo, J. R. AU - Price, R. N. PY - 2012 DA - 2012// TI - Plasmodium vivax: clinical spectrum, risk factors, and pathogenesis JO - Adv Parasitol VL - 80 UR - https://doi.org/10.1016/B978-0-12-397900-1.00003-7 DO - 10.1016/B978-0-12-397900-1.00003-7 ID - Anstey2012 ER - TY - JOUR AU - Naing, C. AU - Whittaker, M. A. AU - Nyunt Wai, V. AU - Mak, J. W. PY - 2014 DA - 2014// TI - Is Plasmodium vivax malaria a severe malaria? A systematic review and meta-analysis JO - PLoS Negl Trop Dis VL - 8 UR - https://doi.org/10.1371/journal.pntd.0003071 DO - 10.1371/journal.pntd.0003071 ID - Naing2014 ER - TY - STD TI - World Health Organization. Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. WHO Evidence Review Group meeting report, 8-9 October 2014, WHO/UNAIDS Building, Geneva, Switzerland. WHO 2015. www.who.int/malaria/mpac/mpac-march2015-erg-g6pd.pdf. Accessed 27 Mar 2017. UR - http://www.who.int/malaria/mpac/mpac-march2015-erg-g6pd.pdf ID - ref11 ER - TY - JOUR AU - Hwang, J. AU - Cullen, K. A. AU - Kachur, S. P. AU - Arugin, P. M. AU - Baird, J. K. PY - 2014 DA - 2014// TI - Severe morbidity and mortality risk from malaria in the United States, 1985-2011 JO - Open Forum Infect Dis VL - 1 UR - https://doi.org/10.1093/ofid/ofu034 DO - 10.1093/ofid/ofu034 ID - Hwang2014 ER - TY - JOUR AU - Battle, K. E. AU - Karhunen, M. S. AU - Bhatt, S. PY - 2014 DA - 2014// TI - Geographical variation in Plasmodium vivax relapse JO - Malaria J VL - 13 UR - https://doi.org/10.1186/1475-2875-13-144 DO - 10.1186/1475-2875-13-144 ID - Battle2014 ER - TY - JOUR AU - White, N. J. PY - 2011 DA - 2011// TI - Determinants of relapse periodicity in Plasmodium vivax malaria JO - Malaria J VL - 10 UR - https://doi.org/10.1186/1475-2875-10-297 DO - 10.1186/1475-2875-10-297 ID - White2011 ER - TY - JOUR AU - Sutanto, I. AU - Tjahjono, B. AU - Basri, H. PY - 2013 DA - 2013// TI - Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.01879-12 DO - 10.1128/AAC.01879-12 ID - Sutanto2013 ER - TY - JOUR AU - Nelwan, E. J. AU - Ekawati, L. L. AU - Tjahjono, B. PY - 2015 DA - 2015// TI - Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia JO - BMC Med VL - 13 UR - https://doi.org/10.1186/s12916-015-0535-9 DO - 10.1186/s12916-015-0535-9 ID - Nelwan2015 ER - TY - JOUR AU - Aung, P. P. AU - Lwin, K. M. AU - Price, R. N. PY - 2011 DA - 2011// TI - Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial JO - Clin Infect Dis VL - 53 UR - https://doi.org/10.1093/cid/cir631 DO - 10.1093/cid/cir631 ID - Aung2011 ER - TY - JOUR AU - Hanf, M. AU - Stephani, A. AU - Basurko, C. AU - Nacher, M. AU - Carme, B. PY - 2009 DA - 2009// TI - Determination of the Plasmodium vivax relapse pattern in Campoi, French Guiana JO - Malaria J VL - 8 UR - https://doi.org/10.1186/1475-2875-8-278 DO - 10.1186/1475-2875-8-278 ID - Hanf2009 ER - TY - JOUR AU - Schwartz, E. AU - Parise, M. AU - Kozarsky, P. AU - Cetron, M. PY - 2003 DA - 2003// TI - Delayed onset of malaria – implications for chemoprophylaxis in travelers JO - New Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa021592 DO - 10.1056/NEJMoa021592 ID - Schwartz2003 ER - TY - JOUR AU - Chu, C. S. AU - White, N. J. PY - 2016 DA - 2016// TI - Management of relapsing Plasmodium vivax malaria JO - Expert Rev Infect Ther VL - 14 UR - https://doi.org/10.1080/14787210.2016.1220304 DO - 10.1080/14787210.2016.1220304 ID - Chu2016 ER - TY - STD TI - United States Centers for Disease Control. The Yellow Book 2016. https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/malaria#1939. Accessed 26 Feb 2017. UR - https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/malaria#1939 ID - ref21 ER - TY - STD TI - The Medical Letter on Drugs and Therapeutics. Advice for Travelers. 2015;57(1466):52–8. ID - ref22 ER - TY - STD TI - The Medical Letter on Drugs and Therapeutics. Drugs Parasitic Infect. 2013; 11(Suppl):e1-31. ID - ref23 ER - TY - STD TI - Public Health England. Guidelines for Malaria Prevention in Travelers from the United Kingdom 2016. Crown copyright 2017; 120. ID - ref24 ER - TY - JOUR AU - Lalloo, D. G. AU - Shingadia, D. AU - Pasvol, G. PY - 2007 DA - 2007// TI - UK malaria treatment guidelines JO - J Infection VL - 54 UR - https://doi.org/10.1016/j.jinf.2006.12.003 DO - 10.1016/j.jinf.2006.12.003 ID - Lalloo2007 ER - TY - BOOK PY - 2014 DA - 2014// TI - Canadian Recommendations for the Prevention and Treatment of Malaria ID - ref26 ER - TY - BOOK PY - 2015 DA - 2015// TI - Guidelines for the Treatment of Malaria ID - ref27 ER - TY - JOUR AU - Ashley, E. A. AU - Recht, J. AU - White, N. J. PY - 2014 DA - 2014// TI - Primaquine: the risks and the benefits JO - Malaria J VL - 13 UR - https://doi.org/10.1186/1475-2875-13-418 DO - 10.1186/1475-2875-13-418 ID - Ashley2014 ER - TY - JOUR AU - Oo, N. N. AU - Bancone, G. AU - Maw, L. Z. PY - 2016 DA - 2016// TI - Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0152304 DO - 10.1371/journal.pone.0152304 ID - Oo2016 ER - TY - JOUR AU - Osorio, L. AU - Carter, N. AU - Arthur, P. PY - 2015 DA - 2015// TI - Performance of the BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax infected subjects JO - Am J Trop Med Hyg VL - 92 UR - https://doi.org/10.4269/ajtmh.14-0298 DO - 10.4269/ajtmh.14-0298 ID - Osorio2015 ER - TY - JOUR AU - Baird, J. K. AU - Dewi, M. AU - Subekti, D. PY - 2015 DA - 2015// TI - Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells JO - Transl Res VL - 165 UR - https://doi.org/10.1016/j.trsl.2014.09.009 DO - 10.1016/j.trsl.2014.09.009 ID - Baird2015 ER - TY - JOUR AU - Berman, J. D. AU - Nielsen, R. AU - Chulay, J. D. PY - 2001 DA - 2001// TI - Causal prophylactic activity of atovaquone-proguanil (Malarone) in a human challenge model JO - Trans Roy Soc Trop Med Hyg VL - 95 UR - https://doi.org/10.1016/S0035-9203(01)90206-8 DO - 10.1016/S0035-9203(01)90206-8 ID - Berman2001 ER - TY - JOUR AU - Jimenez, B. C. AU - Navarro, M. AU - Huerga, H. PY - 2006 DA - 2006// TI - Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis JO - J Travel Med VL - 13 UR - https://doi.org/10.1111/j.1708-8305.2006.00073.x DO - 10.1111/j.1708-8305.2006.00073.x ID - Jimenez2006 ER - TY - JOUR AU - Maguire, J. D. AU - Llewellyn, D. M. PY - 2007 DA - 2007// TI - Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic JO - J Travel Med VL - 14 UR - https://doi.org/10.1111/j.1708-8305.2007.00153.x DO - 10.1111/j.1708-8305.2007.00153.x ID - Maguire2007 ER - TY - JOUR AU - Mavrogordato, A. AU - Lever, A. M. L. PY - 2012 DA - 2012// TI - A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax JO - J Infect VL - 65 UR - https://doi.org/10.1016/j.jinf.2012.04.015 DO - 10.1016/j.jinf.2012.04.015 ID - Mavrogordato2012 ER - TY - CHAP AU - Alving, A. S. AU - Rucker, K. AU - Flanagan, C. L. PY - 1959 DA - 1959// TI - Observations on primaquine in the prophylaxis and cure of vivax malaria BT - Proceedings of the 6th International Congress of Tropical Medicine and Malaria ID - Alving1959 ER - TY - JOUR AU - Baird, J. K. AU - Fryauff, D. J. AU - Hoffman, S. L. PY - 2003 DA - 2003// TI - Primaquine for prevention of malaria in travelers JO - Clin Infect Dis VL - 37 UR - https://doi.org/10.1086/379714 DO - 10.1086/379714 ID - Baird2003 ER - TY - JOUR AU - Zeeman, A. M. AU - Lakshminarayana, S. B. AU - Werff, N. PY - 2016 DA - 2016// TI - PI4 kinase is a prophylactic but not radical curative target in Plasmodium vivax-type malaria parasites JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.03080-15 DO - 10.1128/AAC.03080-15 ID - Zeeman2016 ER - TY - JOUR AU - Bennett, J. W. AU - Pybus, B. S. AU - Yadava, A. PY - 2013 DA - 2013// TI - Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMc1301936 DO - 10.1056/NEJMc1301936 ID - Bennett2013 ER - TY - JOUR AU - Ingram, R. J. AU - Crenna-Darusallam, C. AU - Soebianto, S. AU - Noviyanti, R. AU - Baird, J. K. PY - 2014 DA - 2014// TI - The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in New Guinea JO - Malaria J VL - 13 UR - https://doi.org/10.1186/1475-2875-13-488 DO - 10.1186/1475-2875-13-488 ID - Ingram2014 ER - TY - JOUR AU - Gaedigk, A. AU - Sangkuhl, K. AU - Whirl-Carillo, M. AU - Klein, T. AU - Leeder, J. S. PY - 2016 DA - 2016// TI - Prediction of CYP2D6 phenotype from genotype across world populations JO - Genet Med ID - Gaedigk2016 ER - TY - JOUR AU - Llanos-Cuentas, A. AU - Lacerda, M. V. AU - Rueangweerayut, R. PY - 2014 DA - 2014// TI - Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria: a multicentre, double-blind, randomised, phase 2b dose-selection study JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(13)62568-4 DO - 10.1016/S0140-6736(13)62568-4 ID - Llanos-Cuentas2014 ER - TY - JOUR AU - Walsh, D. S. AU - Eamsila, C. AU - Sasiprapha, T. PY - 2004 DA - 2004// TI - Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multi-drug resistant P. falciparum malaria JO - J Inf Dis VL - 190 UR - https://doi.org/10.1086/424468 DO - 10.1086/424468 ID - Walsh2004 ER - TY - JOUR AU - Nasveld, P. E. AU - Edstein, M. D. AU - Reid, M. PY - 2010 DA - 2010// TI - Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in non-immune subjects JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00354-09 DO - 10.1128/AAC.00354-09 ID - Nasveld2010 ER - TY - JOUR AU - Shanks, G. D. AU - Oloo, A. J. AU - Aleman, G. M. PY - 2001 DA - 2001// TI - A new primaquine analog, tafenoquine (WR238605), for prophylaxis against Plasmodium falciparum malaria JO - Clin Infect Dis VL - 33 UR - https://doi.org/10.1086/324081 DO - 10.1086/324081 ID - Shanks2001 ER - TY - JOUR AU - Baird, J. K. AU - Valecha, N. AU - Duparc, S. AU - White, N. J. AU - Price, R. N. PY - 2016 DA - 2016// TI - Diagnosis and treatment of Plasmodium vivax malaria JO - Am J Trop Med Hyg VL - 95 UR - https://doi.org/10.4269/ajtmh.16-0171 DO - 10.4269/ajtmh.16-0171 ID - Baird2016 ER - TY - JOUR AU - Hill, D. R. AU - Baird, J. K. AU - Parise, M. E. AU - Lewis, L. S. AU - Ryan, E. T. AU - Magill, A. J. PY - 2006 DA - 2006// TI - Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I JO - Am J Trop Med Hyg VL - 75 ID - Hill2006 ER - TY - JOUR AU - John, G. K. AU - Douglas, N. M. AU - Seidlein, L. PY - 2012 DA - 2012// TI - Primaquine radical cure of Plasmodium vivax: a critical review of the literature JO - Malaria J VL - 11 UR - https://doi.org/10.1186/1475-2875-11-280 DO - 10.1186/1475-2875-11-280 ID - John2012 ER - TY - JOUR AU - Price, R. N. AU - Seidlein, L. AU - Valecha, N. PY - 2014 DA - 2014// TI - Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis JO - Lancet Infect Dis VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70855-2 DO - 10.1016/S1473-3099(14)70855-2 ID - Price2014 ER - TY - JOUR AU - Baird, J. K. PY - 2011 DA - 2011// TI - Resistance to chloroquine unhinges vivax malaria therapeutics JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.01296-10 DO - 10.1128/AAC.01296-10 ID - Baird2011 ER -